Related references
Note: Only part of the references are listed.Current understanding of metformin effect on the control of hyperglycemia in diabetes
Hongying An et al.
JOURNAL OF ENDOCRINOLOGY (2016)
Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity
Rebecca J. Ford et al.
BIOCHEMICAL JOURNAL (2015)
Metformin Activates AMP-activated Protein Kinase by Promoting Formation of the αβγ Heterotrimeric Complex
Shumei Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Metformin Pharmacogenomics: Current Status and Future Directions
Aaron C. Pawlyk et al.
DIABETES (2014)
Control of Foxo1 Gene Expression by Co-activator P300
Anne R. Wondisford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)
Jia Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Potential biomarker of metformin action
Ling He et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Metformin improves healthspan and lifespan in mice
Alejandro Martin-Montalvo et al.
NATURE COMMUNICATIONS (2013)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Transcriptional Co-activator p300 Maintains Basal Hepatic Gluconeogenesis
Ling He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
Snapin Mediates Incretin Action and Augments Glucose-Dependent Insulin Secretion
Woo-Jin Song et al.
CELL METABOLISM (2011)
Suppression of AMPK Activation via S485 Phosphorylation by IGF-I during Hyperglycemia Is Mediated by AKT Activation in Vascular Smooth Muscle Cells
Junyu Ning et al.
ENDOCRINOLOGY (2011)
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Simon A. Hawley et al.
CELL METABOLISM (2010)
PKA phosphorylates and inactivates AMPKα to promote efficient lipolysis
Nabil Djouder et al.
EMBO JOURNAL (2010)
Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein
Ling He et al.
CELL (2009)
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics
Y. Shu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care
M. N. Cook et al.
DIABETIC MEDICINE (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP
Rebecca L. Hurley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues
LS Kirschner et al.
CANCER RESEARCH (2005)
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
RS Hundal et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Glucagon replacement via micro-osmotic pump corrects hypoglycemia and α-cell hyperplasia in prohormone convertase 2 knockout mice
GC Webb et al.
DIABETES (2002)
Share Paper
